Bavarian Nordic Announces Appointment of Jean-Christophe May as Executive Vice President and Chief Commercial Officer

    NEXT STORY
    Oncology Venture advancing towards next milestone in its clinical development of IXEMPRA®.
    PREV STORY
    Innate Pharma third quarter 2019 report
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    VBI Vaccines Prices Concurrent Public Offering and Registered Direct Offering for Aggregate Proceeds of $63.5 Million

    CAMBRIDGE, Mass., Oct. 26, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (TSX:VBV) (VBI), a ...

    author_avatar
    NASDAQ Market News

    Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences

    PLYMOUTH MEETING, Pa., Jan. 30, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

    author_avatar
    NASDAQ Market News

    Coherus BioSciences Receives Complete Response Letter from FDA for its Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate)

    REDWOOD CITY, Calif., June 12, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ:CHRS), today ...

    author_avatar
    NASDAQ Market News